Mouwasat Medical Services Co.
TTADAWUL:400255.50
SAR
-1.85
(-3.23%)
Mouwasat Medical Services Co.
TADAWUL:4002
(Saudi Exchange)
Recent
price
55.50
P/E
ratio
14.98
div
yld
1.80%
ROIC.AI
Capital Structure
SAR
•
in mil. unless spec.Working Capital
SAR
•
in mil. unless spec.Growth Rates
SAR
•
in mil. unless spec.Quarterly Revenue
SAR
•
in mil. unless spec.Quarterly Earnings Per Share
SAR
•
in mil. unless spec.Quarterly Dividends Per Share
SAR
•
in mil. unless spec.- Similar Companies
- Business
- Mouwasat Medical Services Company Mouwasat Medical Services Company (4002.SR) engages in the acquisition, management, operation, and maintenance of hospitals, medical centers, drug stores, and pharmacies primarily in the Kingdom of Saudi Arabia. Founded in 1974 and headquartered in Dammam, the company operates facilities in key locations including Dammam, Jubail, Qatif, Madinah, Riyadh, and Al-Khobar, serving patients through a network of general hospitals and specialized centers offering comprehensive medical and surgical services; eye care; long-term care; rehabilitation; stroke units; cardiology; nuclear medicine; fertility treatments; diabetes and diabetic foot care; skin care; Badana clinics; inpatient pharmacy services; TPN and IV medication preparation; chemotherapy preparation; anti-coagulant clinics; clinical pharmacy; emergency care; physiotherapy; laboratory services; comprehensive medical examinations; robotic surgery; endoscopy; orthopedic care; neurosurgery; interventional radiology; pediatric surgery; geriatric medicine; blood banking; and advanced diagnostics including PET scans, MRI, CT, ultrasound, and mammography. The company targets diverse customer segments including inpatients, outpatients, and specialized treatment seekers, with a strong emphasis on quality through multiple international accreditations such as Joint Commission International, American College of Radiology across various imaging modalities, College of American Pathologists, CARF for rehabilitation, and Centers of Excellence from SRC in areas like neurosurgery, orthopedics, urology, endoscopy, minimally invasive surgery, gynecology, and kidney stone management. Mouwasat maintains a commitment to Saudi national competencies, attracting skilled local doctors, and leverages advanced technologies including artificial intelligence for healthcare enhancement while aligning with Saudi Vision 2030 initiatives in digitalization, patient safety, and operational efficiency. In recent developments, the company completes expansions such as the Dammam Hospital upgrade and advances plans to significantly increase bed capacity by approximately 58% to 2,341 beds and clinics by 33% to 744 through new hospitals in the Central and Western regions between 2024 and 2027, alongside board approval in September 2025 for a new SAR 1.38 billion hospital project in Al-Ahsa and expansions in Qatif and Riyadh to address strong private healthcare demand via horizontal growth into new regions. These initiatives, financed through a mix of 20% self-funding and 80% local bank loans against existing SAR 500 million debt, incorporate core and specialized disciplines tailored to regional needs and emphasize technological advancements like AI. Mouwasat continues to demonstrate operational excellence with recent medical successes in robotic surgeries for tumors, congenital deformities, and complex cases across its facilities as of November 2025.